{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T23:00:59Z","timestamp":1790290859133,"version":"4.1.0"},"update-to":[{"DOI":"10.1002\/14651858.cd001423.pub3","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2023,6,22]],"date-time":"2023-06-22T00:00:00Z","timestamp":1687392000000}}],"reference-count":220,"publisher":"Wiley","issue":"6","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd001423.pub4","type":"journal-article","created":{"date-parts":[[2023,6,24]],"date-time":"2023-06-24T18:19:57Z","timestamp":1687630797000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Serenoa repens for the treatment of lower urinary tract symptoms due to benign prostatic enlargement"],"prefix":"10.1002","volume":"2023","author":[{"given":"Juan VA","family":"Franco","sequence":"additional","affiliation":[{"name":"Institute of General Practice, Medical Faculty; Heinrich-Heine-University D\u00fcsseldorf; D\u00fcsseldorf Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonel","family":"Trivisonno","sequence":"additional","affiliation":[{"name":"Department of Health Science; Universidad Nacional de La Matanza; San Justo Argentina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia J","family":"Sgarbossa","sequence":"additional","affiliation":[{"name":"Department of Health Science; Universidad Nacional de La Matanza; San Justo Argentina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gustavo Ariel","family":"Alvez","sequence":"additional","affiliation":[{"name":"Medical School; Instituto Universitario Hospital Italiano de Buenos Aires; Buenos Aires Argentina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilia","family":"Fieiras","sequence":"additional","affiliation":[{"name":"Medical School; Instituto Universitario Hospital Italiano de Buenos Aires; Buenos Aires Argentina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camila Micaela","family":"Escobar Liquitay","sequence":"additional","affiliation":[{"name":"Department of Research; Instituto Universitario Hospital Italiano de Buenos Aires; Buenos Aires Chile"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae Hung","family":"Jung","sequence":"additional","affiliation":[{"name":"Department of Urology; Yonsei University Wonju College of Medicine; Wonju Korea, South"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2023,6,22]]},"reference":[{"issue":"12","key":"10.1002\/14651858.CD001423.pub4-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.2298\/VSP110620029A","article-title":"Does the addition of Serenoa repens to tamsulosin improve its therapeutical efficacy in benign prostatic hyperplasia?","volume":"70","author":"Argirovic","year":"2013","journal-title":"Vojnosanit Pregl"},{"issue":"8","key":"10.1002\/14651858.CD001423.pub4-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/S1569-9056(09)74795-5","article-title":"Tamsulosin with or without Serenoa repens in benign prostatic hyperplasia: The Comb TAMSR trial","volume":"8","author":"Argirovic","year":"2009","journal-title":"European Urology Supplements"},{"issue":"2","key":"10.1002\/14651858.CD001423.pub4-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"486-492","DOI":"10.1016\/j.juro.2012.09.037","article-title":"The effect of increasing doses of saw palmetto fruit extract on serum prostate specific antigen: analysis of the CAMUS randomized trial","volume":"189","author":"Andriole","year":"2013","journal-title":"Journal of Urology"},{"issue":"4","key":"10.1002\/14651858.CD001423.pub4-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1016\/j.juro.2012.10.002","article-title":"Safety and toxicity of saw palmetto in the CAMUS trial","volume":"189","author":"Avins","year":"2013","journal-title":"Journal of Urology"},{"issue":"12","key":"10.1002\/14651858.CD001423.pub4-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1001\/jama.2011.1364","article-title":"Effect of increasing doses of Saw palmetto extract on lower urinary tract symptoms","volume":"306","author":"Barry","year":"2011","journal-title":"JAMA"},{"issue":"4","key":"10.1002\/14651858.CD001423.pub4-BIB0006|cit6","first-page":"498","article-title":"Factors that affect men's feelings about their urination: findings from a multi-center clinical trial of phytotherapy to treat lower urinary tract symptoms","volume":"9","author":"Cantor","year":"2012","journal-title":"Clinical Trials (London, England)"},{"issue":"4 SUPPL. 1","key":"10.1002\/14651858.CD001423.pub4-BIB0007|cit7","first-page":"e700","article-title":"Comparison of the american urological association symptom index with a short version, uwin, in a clinical phytotherapy trial","volume":"187","author":"Crawford","year":"2012","journal-title":"Journal of Urology"},{"issue":"6","key":"10.1002\/14651858.CD001423.pub4-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"2288","DOI":"10.1016\/j.juro.2012.07.104","article-title":"Associations between improvements in lower urinary tract symptoms and sleep disturbance over time in the CAMUS trial","volume":"188","author":"Helfand","year":"2012","journal-title":"Journal of Urology"},{"issue":"6","key":"10.1002\/14651858.CD001423.pub4-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1016\/j.juro.2011.02.012","article-title":"The relationship between lower urinary tract symptom severity and sleep disturbance in the CAMUS trial","volume":"185","author":"Helfand","year":"2011","journal-title":"Journal of Urology"},{"issue":"4","key":"10.1002\/14651858.CD001423.pub4-BIB0010|cit10","first-page":"e703","article-title":"Improvements in lower urinary tract symptom severity are associated with improvements in sleep disturbance over time","volume":"187","author":"Helfand","year":"2012","journal-title":"Journal of Urology"},{"issue":"6","key":"10.1002\/14651858.CD001423.pub4-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"628-636","DOI":"10.1177\/1740774509352199","article-title":"Redesigning a large-scale clinical trial in response to negative external trial results: the CAMUS study of phytotherapy for benign prostatic hyperplasia","volume":"6","author":"Lee","year":"2009","journal-title":"Clinical Trials (London, England)"},{"issue":"4","key":"10.1002\/14651858.CD001423.pub4-BIB0012|cit12","first-page":"521","article-title":"Participant perception of treatment assignment is related to symptom severity in a clinical trial of phytotherapy","volume":"9","author":"Lee","year":"2012","journal-title":"Clinical Trials"},{"issue":"5","key":"10.1002\/14651858.CD001423.pub4-BIB0013|cit13","first-page":"469-472","article-title":"Recruitment of participants to a clinical trial of botanical therapy for benign prostatic hyperplasia","volume":"17","author":"Lee","year":"2011","journal-title":"Journal of Alternative and Complementary Medicine (New York, NY)"},{"issue":"1","key":"10.1002\/14651858.CD001423.pub4-BIB0014|cit14","first-page":"48-52","article-title":"Treatment assignment guesses by study participants in a double-blind dose escalation clinical trial of saw palmetto","volume":"20","author":"Lee","year":"2014","journal-title":"Journal of Alternative and Complementary Medicine (New York, NY)"},{"key":"10.1002\/14651858.CD001423.pub4-BIB0015|cit15","unstructured":"Complementary and alternative medicine for urological symptoms (CAMUS) https:\/\/clinicaltrials.gov\/ct2\/show\/NCT00603304"},{"issue":"3 SUPPL. 1","key":"10.1002\/14651858.CD001423.pub4-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1016\/j.urology.2011.07.427","article-title":"The effect of increasing doses of a saw palmetto fruit extract on lower urinary tract symptoms attributed to benign prostatic hyperplasia: a randomized trial","volume":"78","author":"Roehrborn","year":"2011","journal-title":"Urology"},{"key":"10.1002\/14651858.CD001423.pub4-BIB0017|cit17","unstructured":"Efficacy of two formulations of Sabal serrulata; a double-blind; randomized; placebo-controlled phase III study https:\/\/www.clinicaltrialsregister.eu\/ctr-search\/search?query=2006-003532-30"},{"issue":"25","key":"10.1002\/14651858.CD001423.pub4-BIB0018|cit18","first-page":"127","article-title":"Saw palmetto fruit extract for treatment of benign prostatic hyperplasia. Results of a placebo-controlled double-blind study","volume":"141","author":"Bauer","year":"1999","journal-title":"MMW Fortschritte der Medizin"},{"issue":"6","key":"10.1002\/14651858.CD001423.pub4-BIB0019|cit19","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1056\/NEJMoa053085","article-title":"Saw palmetto for benign prostatic hyperplasia","volume":"354","author":"Bent","year":"2006","journal-title":"The New England Journal of Medicine"},{"issue":"4","key":"10.1002\/14651858.CD001423.pub4-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S0022-5347(18)35759-8","article-title":"A randomized controlled trial of saw palmetto for the treatment of benign prostatic hyperplasia","volume":"173","author":"Bent","year":"2005","journal-title":"Journal of Urology"},{"key":"10.1002\/14651858.CD001423.pub4-BIB0021|cit21","unstructured":"Saw Palmetto Extract in Benign Prostatic Hyperplasia https:\/\/clinicaltrials.gov\/ct2\/show\/NCT00037154"},{"key":"10.1002\/14651858.CD001423.pub4-BIB0022|cit22","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1177\/039156038305000615","article-title":"Serenoa repens extract and placebo in prostatic benign hyperplasia: clinical results","volume":"50","author":"Boccafoschi","year":"1983","journal-title":"Urologia"},{"issue":"6","key":"10.1002\/14651858.CD001423.pub4-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1111\/j.1464-410X.1990.tb07199.x","article-title":"Treatment of benign prostatic hyperplasia with phytosterols","volume":"66","author":"Carbin","year":"1990","journal-title":"British Journal of Urology"},{"key":"10.1002\/14651858.CD001423.pub4-BIB0024|cit24","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1111\/j.1365-2125.1984.tb02491.x","article-title":"A double-blind trial of an extract of the plant Serenoa repens in benign prostatic hyperplasia","volume":"18","author":"Champault","year":"1984","journal-title":"British Journal of Clinical Pharmacology"},{"key":"10.1002\/14651858.CD001423.pub4-BIB0025|cit25","unstructured":"A study looking at the effectiveness of a oral herbal supplement for helping to manage the symptoms of enlarged prostate https:\/\/anzctr.org.au\/Trial\/Registration\/TrialReview.aspx?ACTRN=12610000168055"},{"key":"10.1002\/14651858.CD001423.pub4-BIB0026|cit26","doi-asserted-by":"crossref","unstructured":"Coulson S Rao A Beck SL Steels E Gramotnev H Vitetta L A phase II randomised double-blind placebo-controlled clinical trial investigating the efficacy and safety of ProstateEZE Max: a herbal medicine preparation for the management of symptoms of benign prostatic hypertrophy Complementary Therapies in Medicine 2013 321 3 172 9 10.1016\/j.ctim.2013.01.007 23642948","DOI":"10.1016\/j.ctim.2013.01.007"},{"key":"10.1002\/14651858.CD001423.pub4-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"291","DOI":"10.2165\/00044011-199509050-00007","article-title":"Placebo-controlled evaluation of the efficacy and tolerability of Permixon\u00ae in benign prostatic hyperplasia after the exclusion of placebo responders","volume":"5","author":"Descotes","year":"1995","journal-title":"Clinical Drug Investigation"},{"issue":"6","key":"10.1002\/14651858.CD001423.pub4-BIB0028|cit28","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1016\/s0090-4295(01)01442-x","article-title":"Randomized, double-blind, placebo-controlled trial of saw palmetto in men with lower urinary tract symptoms","volume":"58","author":"Gerber","year":"2001","journal-title":"Urology"},{"key":"10.1002\/14651858.CD001423.pub4-BIB0029|cit29","first-page":"395","article-title":"Tamsulosin with or without Serenoa repens in benign prostatic hyperplasia: the OCOS trial","volume":"12","author":"Gl\u00e9main","year":"2002","journal-title":"Progr\u00e8s en Urologie"},{"key":"10.1002\/14651858.CD001423.pub4-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1007\/s11255-006-9106-5","article-title":"A prospective study of the efficacy of Serenoa repens, tamsulosin, and Serenoa repens plus tamsulosin treatment for patients with benign prostate hyperplasia","volume":"39","author":"Hizli","year":"2007","journal-title":"International Urology and Nephrology"},{"key":"10.1002\/14651858.CD001423.pub4-BIB0031|cit31","first-page":"1108.6","article-title":"Effects of Saw Palmetto Extracted Oil Supplementation on Human Benign Prostatic Hyperplasia","volume":"22","author":"Hong","year":"2008","journal-title":"FASEB Journal"},{"issue":"4","key":"10.1002\/14651858.CD001423.pub4-BIB0032|cit32","doi-asserted-by":"publisher","first-page":"323","DOI":"10.4162\/nrp.2009.3.4.323","article-title":"Effects of pumpkin seed oil and saw palmetto oil in Korean men with symptomatic benign prostatic hyperplasia","volume":"3","author":"Hong","year":"2009","journal-title":"Nutrition Research and Practice"},{"key":"10.1002\/14651858.CD001423.pub4-BIB0033|cit33","unstructured":"Iacono F Ruffo A Prezioso D Romeo G Illiano E Romis L Combined treatment with Tradamixina\u00ae and Serenoa repens decreases PSA levels and prostate inflammation, improving the lower urinary tract symptoms (LUTS). A randomized, double-blind, placebo-controlled study on 185 patients: PS-04-009 Journal of Sexual Medicine 2015 2 Suppl 3 201 10.1111\/jsm.12872_2"},{"issue":"4","key":"10.1002\/14651858.CD001423.pub4-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"1137-1146","DOI":"10.1007\/s11255-006-9173-7","article-title":"Efficacy and safety of a combination of Sabal and Urtica extract in lower urinary tract symptoms\u2014long-term follow-up of a placebo-controlled, double-blind, multicenter trial","volume":"39","author":"Lopatkin","year":"2007","journal-title":"International Urology and Nephrology"},{"issue":"2","key":"10.1002\/14651858.CD001423.pub4-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s00345-005-0501-9","article-title":"Combined extract of sabal palm and nettle in the treatment of patients with lower urinary tract symptoms in the double blind, placebo-controlled trial","volume":"23","author":"Lopatkin","year":"2005","journal-title":"World Journal of Urology"},{"issue":"2","key":"10.1002\/14651858.CD001423.pub4-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"139-146","DOI":"10.1007\/s00345-005-0501-9","article-title":"Long-term efficacy and safety of a combination of sabal and urtica extract for lower urinary tract symptoms\u2014a placebo-controlled, double-blind, multicenter trial","volume":"23","author":"Lopatkin","year":"2005","journal-title":"World Journal of Urology"},{"issue":"2","key":"10.1002\/14651858.CD001423.pub4-BIB0037|cit37","first-page":"12, 14-9","article-title":"Combined extract of Sabal palm and nettle in the treatment of patients with lower urinary tract symptoms in double blind, placebo-controlled trial","author":"Lopatkin","year":"2006","journal-title":"Urologiia (Moscow, Russia : 1999)"},{"key":"10.1002\/14651858.CD001423.pub4-BIB0038|cit38","first-page":"S19","article-title":"Long-term efficacy and safety of a combination of sabal and urtica extracts in LUTS\u2014a placebo-controlled, double-blind, multicenter trial","volume":"40 (Suppl 1)","author":"Sivkov","year":"2001","journal-title":"Urologe A"},{"issue":"4","key":"10.1002\/14651858.CD001423.pub4-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1177\/039156038305000414","article-title":"Medical treatment of benign prostatic hyperplasia: efficacy of the extract of Serenoa repens (Permixon\u00ae) compared to that of the extract of Pygeum africanum and a placebo","volume":"50","author":"Mandressi","year":"1983","journal-title":"Urologia"},{"issue":"5","key":"10.1002\/14651858.CD001423.pub4-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1016\/S0022-5347(05)67641-0","article-title":"Effects of a saw palmetto herbal blend in men with symptomatic benign prostatic hyperplasia","volume":"163","author":"Marks","year":"2000","journal-title":"The Journal of Urology"},{"issue":"4","key":"10.1002\/14651858.CD001423.pub4-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/S0022-5347(18)38867-0","article-title":"Effects of finasteride and saw palmetto on BPSA, propsa, and CPSA in men with benign prostatic hyperplasia","volume":"171","author":"Sokoll","year":"2004","journal-title":"Journal of Urology"},{"issue":"4","key":"10.1002\/14651858.CD001423.pub4-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1007\/s001310050033","article-title":"Efficacy of a Sabal-Urtica Combination Drug in the Treatment of Benign Prostatic Hyperplasia (BPH)","volume":"36","author":"Metzker","year":"1996","journal-title":"Der Urologe B"},{"key":"10.1002\/14651858.CD001423.pub4-BIB0043|cit43","unstructured":"Serenoa repens, lycopene and selenium vs. tamsulosin for the treatment of lower urinary tract symptoms (LUTS)\/ Benign prostatic hyperplasia (BPH) https:\/\/www.isrctn.com\/ISRCTN78639965"},{"key":"10.1002\/14651858.CD001423.pub4-BIB0044|cit44","doi-asserted-by":"crossref","unstructured":"Morgia G Russo GI Voce S Palmieri F Gentile M Giannantoni A Serenoa repens, lycopene and selenium versus tamsulosin for the treatment of LUTS\/BPH. An Italian multicenter double-blinded randomized study between single or combination therapy (PROCOMB trial) Prostate 2014 74 15 1471 80 10.1002\/pros.22866 25154739","DOI":"10.1002\/pros.22866"},{"key":"10.1002\/14651858.CD001423.pub4-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1023\/A:1015227604041","article-title":"Randomized trial of a combination of natural products (Cernitin, saw palmetto, beta-sitosterol, vitamin E) on symptoms of benign prostatic hyperplasia (BPH)","volume":"33","author":"Preuss","year":"2001","journal-title":"International Urology and Nephrology"},{"key":"10.1002\/14651858.CD001423.pub4-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/j.1464-410X.1986.tb05424.x","article-title":"The value of Permixon in benign prostatic hypertrophy","volume":"58","author":"Reece Smith","year":"1986","journal-title":"British Journal of Urology"},{"key":"10.1002\/14651858.CD001423.pub4-BIB0047|cit47","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1159\/000366521","article-title":"Comparison of tamsulosin plus serenoa repens with tamsulosin in the treatment of benign prostatic hyperplasia in Korean men: 1-year randomized open label study","volume":"2","author":"Ryu","journal-title":"Urologia Internationalis"},{"key":"10.1002\/14651858.CD001423.pub4-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.juro.2007.09.032","article-title":"Effect of saw palmetto soft gel capsule on lower urinary tract symptoms associated with benign prostatic hyperplasia: a randomized trial in Shanghai, China","volume":"179","author":"Shi","year":"2008","journal-title":"The Journal of Urology"},{"issue":"1","key":"10.1002\/14651858.CD001423.pub4-BIB0049|cit49","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/s12894-020-00648-9","article-title":"A double blind, placebo-controlled randomized comparative study on the efficacy of phytosterol-enriched and conventional saw palmetto oil in mitigating benign prostate hyperplasia and androgen deficiency","volume":"20","author":"Sudeep","year":"2020","journal-title":"BMC Urology"},{"key":"10.1002\/14651858.CD001423.pub4-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1046\/j.1464-410X.2003.04316.x","article-title":"Serenoa repens extract for benign prostate hyperplasia: a randomized controlled trial","volume":"92","author":"Willetts","year":"2003","journal-title":"British Journal of Urology International"},{"key":"10.1002\/14651858.CD001423.pub4-BIB0051|cit51","unstructured":"Effects of Saw Palmtto extract in binign prostatic hyperplasia and sexual function: a multicenter, randomized, double-blind, placebo-controlled trial http:\/\/www.chictr.org.cn\/showproj.aspx?proj=5985"},{"key":"10.1002\/14651858.CD001423.pub4-BIB0052|cit52","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.urology.2019.02.030","article-title":"Efficacy and Safety of Serenoa repens Extract Among Patients with Benign Prostatic Hyperplasia in China: A Multicenter, Randomized, Double-blind, Placebo-controlled Trial","volume":"129","author":"Ye","year":"2019","journal-title":"Urology"},{"issue":"3","key":"10.1002\/14651858.CD001423.pub4-BIB0053|cit53","first-page":"211","article-title":"Symptomatic treatment of benign hypertrophy of the prostate. Comparative study of prazosin and Serenoa repens","volume":"45","author":"Adriazola Semino","year":"1992","journal-title":"Archivos Espanoles de Urologia"},{"issue":"4","key":"10.1002\/14651858.CD001423.pub4-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"967","DOI":"10.3390\/jcm11040967","article-title":"Efficacy and Safety of the Hexanic Extract of Serenoa repens vs. Watchful Waiting in Men with Moderate to Severe LUTS-BPH: Results of a Paired Matched Clinical Study","volume":"11","author":"Alcaraz","year":"2022","journal-title":"Journal of Clinical Medicine"},{"issue":"9","key":"10.1002\/14651858.CD001423.pub4-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/jcm9092909","article-title":"Clinical benefit of tamsulosin and the hexanic extract of serenoa repens, in combination or as monotherapy, in patients with moderate\/severe luts-bph: A subset analysis of the qualiprost study","volume":"9","author":"Alcaraz","year":"2020","journal-title":"Journal of Clinical Medicine"},{"issue":"2","key":"10.1002\/14651858.CD001423.pub4-BIB0056|cit56","first-page":"129","article-title":"Comparison of phytotherapy with alpha adrenocepters blockers in the treatment of symptomatic benign prostatic hyperplasia","volume":"34","author":"Ali","year":"2020","journal-title":"Journal of Postgraduate Medical Institute"},{"key":"10.1002\/14651858.CD001423.pub4-BIB0057|cit57","first-page":"47","article-title":"Efficacy and safety of prostamol-Uno in patients with chronic abacterial prostatitis","volume":"1","author":"Aliaev","year":"2006","journal-title":"Urologiia"},{"key":"10.1002\/14651858.CD001423.pub4-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/sj.pcan.4500477","article-title":"Early urodynamic effects of the lipido-sterolic extract of Serenoa repens (Permixon\u00ae) in patients with lower urinary tract symptoms due to benign prostatic hyperplasia","volume":"3","author":"Al-Shukri","year":"2000","journal-title":"Prostate Cancer and Prostatic Diseases"},{"issue":"56","key":"10.1002\/14651858.CD001423.pub4-BIB0059|cit59","first-page":"4","article-title":"Appreciation of the efficacy of Permixon in daily practice: multicenter study","volume":"5","author":"Authi\u00e9","year":"1987","journal-title":"Comptes Rendus de Th\u00e9rapeutique et de Pharmacologie Clinique"},{"issue":"1","key":"10.1002\/14651858.CD001423.pub4-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s001200050154","article-title":"Combined Sabal extract and Urtica extract versus finasteride in benign prostatic hyperplasia (stages I-II)","volume":"37","author":"Bartsch","year":"1998","journal-title":"UROLOGE A"},{"key":"10.1002\/14651858.CD001423.pub4-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1002\/(SICI)1099-1573(199712)11:8<558::AID-PTR158>3.0.CO;2-U","article-title":"Efficacy and safety of the extract of Serenoa repens in the treatment of benign prostatic hyperplasia: therapeutic equivalence between twice and once daily dosage forms","volume":"1","author":"Braeckman","year":"1997","journal-title":"Phytotherapy Research"},{"key":"10.1002\/14651858.CD001423.pub4-BIB0062|cit62","first-page":"247","article-title":"A double-blind, placebo-controlled study of the plant extract Serenoa repens in the treatment of benign hyperplasia of the prostate","volume":"9","author":"Braeckman","year":"1997","journal-title":"European Journal of Clinical Research"},{"issue":"7","key":"10.1002\/14651858.CD001423.pub4-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/S0011-393X(05)80771-4","article-title":"The extract of Serenoa repens in the treatment of benign prostatic hyperplasia: a multicenter open study","volume":"55","author":"Braeckman","year":"1994","journal-title":"Current Therapeutic Research"},{"issue":"4","key":"10.1002\/14651858.CD001423.pub4-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"184-189","DOI":"10.4081\/aiua.2013.4.184","article-title":"An improvement in sexual function is related to better quality of life, regardless of urinary function improvement: results from the IDIProst Gold Study","volume":"85","author":"Cai","year":"2013","journal-title":"Archivio italiano di urologia e andrologia"},{"issue":"4","key":"10.1002\/14651858.CD001423.pub4-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/(SICI)1097-0045(199610)29:4<231::AID-PROS4>3.0.CO;2-E","article-title":"Comparison of phytotherapy (Permixon) with finasteride in the treatment of benign prostate hyperplasia: a randomized international study of 1,098 patients","volume":"29","author":"Carraro","year":"1996","journal-title":"The Prostate"},{"issue":"1","key":"10.1002\/14651858.CD001423.pub4-BIB0066|cit66","first-page":"39","article-title":"Extract of saw palmetto for treatment of symptomatic benign prostatic hyperplasia","volume":"1","author":"Carraro","year":"1998","journal-title":"Integrative Medicine"},{"issue":"2","key":"10.1002\/14651858.CD001423.pub4-BIB0067|cit67","first-page":"122","article-title":"Mepartricin versus Serenoa repens: double-blind study in 20 cases of benign prostate hypertrophy","volume":"6","author":"Comar","year":"1986","journal-title":"Rivista Italiana di Biologia e Medicina"},{"key":"10.1002\/14651858.CD001423.pub4-BIB0068|cit68","unstructured":"A Clinical Study to Evaluate the Safety and Efficacy of Capsule Outflo in Patients with Benign Prostatic Hyperplasia https:\/\/trialsearch.who.int\/Trial2.aspx?TrialID=CTRI\/2012\/10\/003049"},{"key":"10.1002\/14651858.CD001423.pub4-BIB0069|cit69","unstructured":"A clinical study to assess the Efficacy and Safety of SAW-1720 in Benign Prostate Hyperplasia patients https:\/\/trialsearch.who.int\/Trial2.aspx?TrialID=CTRI\/2020\/09\/027521"},{"key":"10.1002\/14651858.CD001423.pub4-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.eururo.2004.01.015","article-title":"Evaluation of the clinical benefit of Permixon and tamsulosin in severe BPH patients\u2014PERMAL study subset analysis","volume":"45","author":"Debruyne","year":"2004","journal-title":"European Urology"},{"issue":"3","key":"10.1002\/14651858.CD001423.pub4-BIB0071|cit71","first-page":"326","article-title":"Evaluation of the clinical benefit of permixon((R)) and tamsulosin in severe BPH patients\u2014PERMAL study subset analysis","volume":"14","author":"Debruyne","year":"2004","journal-title":"PROGRES EN UROLOGIE"},{"issue":"3","key":"10.1002\/14651858.CD001423.pub4-BIB0072|cit72","first-page":"384","article-title":"Comparison of a phytotherapeutic agent (Permixon) with an alpha-blocker (Tamsulosin) in the treatment of benign prostatic hyperplasia: a 1-year randomized international study","volume":"12","author":"Debruyne","year":"2002","journal-title":"Progres en Urologie"},{"key":"10.1002\/14651858.CD001423.pub4-BIB0073|cit73","first-page":"497","article-title":"Comparison of a phytotherapeutic agent (Permixon\u00ae) with an a-blocker (tamsulosin) in the treatment of benign prostatic hyperplasia: a 1-year randomized international study","volume":"41","author":"Debruyne","year":"2002","journal-title":"Progr\u00e8s en Urologie"},{"issue":"5-6","key":"10.1002\/14651858.CD001423.pub4-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1159\/000503735","article-title":"A Prospective, Open-Label Comparison of Tamsulosin plus Serenoa repens and Bovine Colostrum versus Tamsulosin Alone in the Treatment of Benign Prostatic Hyperplasia","volume":"104","author":"Di Maida","year":"2020","journal-title":"Urologia Internationalis"},{"issue":"4","key":"10.1002\/14651858.CD001423.pub4-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1159\/000474863","article-title":"Evidence that Serenoa repens extract displays an antiestrogenic activity in prostatic tissue of benign prostatic hypertrophy patients","volume":"21","author":"Di Siverio","year":"1992","journal-title":"European Urology"},{"issue":"6","key":"10.1002\/14651858.CD001423.pub4-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S1569-9056(10)61445-5","article-title":"Pharmacoeconomic evaluation of three different medications for lower urinary tract symptoms associated with BPH: Herbal extract versus standard drugs","volume":"9","author":"Duborija-Kovacevic","year":"2010","journal-title":"European Urology, Supplements"},{"issue":"3","key":"10.1002\/14651858.CD001423.pub4-BIB0077|cit77","first-page":"222","article-title":"Efficacy and safety of a combination of sabal and urtica extract in lower urinary tract symptoms. A randomized, double-blind study versus tamsulosin","volume":"56","author":"Engelmann","year":"2006","journal-title":"Arzneimittel-Forschung"},{"key":"10.1002\/14651858.CD001423.pub4-BIB0078|cit78","unstructured":"Exploratory study of L.S.E.S.r. (PERMIXON\u00ae 160 mg hard capsule) versus Tamsulosine LP activity on inflammation biomarkers in the treatment of urinary symptoms related to BPH, A multinational, multicentric, randomised, double-blind, parallel-group prospect https:\/\/www.clinicaltrialsregister.eu\/ctr-search\/trial\/2011-005307-33\/results"},{"issue":"6","key":"10.1002\/14651858.CD001423.pub4-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/S0090-4295(98)00143-5","article-title":"Saw palmetto (Serenoa repens) in men with lower urinary tract symptoms: effects on urodynamic parameters and voiding symptoms","volume":"51","author":"Gerber","year":"1998","journal-title":"Urology"},{"issue":"2","key":"10.1002\/14651858.CD001423.pub4-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/BF02853174","article-title":"The lipidosterolic extract of Serenoa repens in the treatment of benign prostatic hyperplasia: a comparison of two dosage regimens","volume":"19","author":"Giannakopoulos","year":"2002","journal-title":"Advances in Natural Therapy"},{"issue":"2","key":"10.1002\/14651858.CD001423.pub4-BIB0081|cit81","first-page":"94","article-title":"Multicentre study on the efficacy and tolerability of an extract of Serenoa repens in patients with chronic benign prostate conditions associated with inflammation","volume":"84","author":"Giulianelli","year":"2012","journal-title":"Archivio Italiano di Urologia e Andrologia"},{"issue":"1","key":"10.1002\/14651858.CD001423.pub4-BIB0082|cit82","first-page":"97","article-title":"Comparative effects of alfuzosin versus Serenoa repens in the treatment of symptomatic benign prostatic hyperplasia","volume":"48","author":"Grasso","year":"1995","journal-title":"Archivos Espa\u00f1oles de Urolog\u00eda"},{"issue":"6","key":"10.1002\/14651858.CD001423.pub4-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"S160","DOI":"10.1016\/j.jsxm.2020.04.126","article-title":"Improvement of sexual functions in men with benign prostatic hyperplasia with long-term use of the Serenoa repens extract","volume":"17","author":"Gurzhenko","year":"2020","journal-title":"Journal of Sexual Medicine"},{"issue":"10","key":"10.1002\/14651858.CD001423.pub4-BIB0084|cit84","first-page":"413-420","article-title":"Efficacy and tolerability of Roystonea regia (D-004) and saw palmetto lipid extracts in men with symptomatic benign prostatic hyperplasia: a 24 weeks study","volume":"175","author":"Guzman","year":"2016","journal-title":"Gazzetta medica italiana archivio per LE scienze mediche"},{"key":"10.1002\/14651858.CD001423.pub4-BIB0085|cit85","unstructured":"D-004 in patients with Bening Prostatic Hyperplasia https:\/\/rpcec.sld.cu\/en\/trials\/RPCEC00000138-En"},{"issue":"SUPPL. 2","key":"10.1002\/14651858.CD001423.pub4-BIB0086|cit86","first-page":"195","article-title":"Prostatic volume does not correlate with efficacy of treatment for mild to moderate benign prostatic hyperplasia using either finasteride or phytotherapy (permixon\u00ae)","volume":"80","author":"Hamdv","year":"1997","journal-title":"British Journal of Urology"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD001423.pub4-BIB0087|cit87","first-page":"206","article-title":"Influence of age and endocrine treatments (permixon \u00ae and finasteride) on sexual function in benign prostatic hyperplasia (BPH) patients","volume":"80","author":"Raynaud","year":"1997","journal-title":"British Journal of Urology"},{"issue":"12","key":"10.1002\/14651858.CD001423.pub4-BIB0088|cit88","first-page":"1098","article-title":"Efficacy and safety of Saw Palmetto Extract Capsules in the treatment of benign prostatic hyperplasia","volume":"21","author":"Ju","year":"2015","journal-title":"Zhonghua nan ke xue [National journal of andrology]"},{"issue":"16","key":"10.1002\/14651858.CD001423.pub4-BIB0089|cit89","doi-asserted-by":"crossref","first-page":"1857-1867","DOI":"10.1002\/pros.23059","article-title":"Effects of hexanic extract of Serenoa repens (Permixon\u00ae 160\u2009mg) on inflammation biomarkers in the treatment of lower urinary tract symptoms related to benign prostatic hyperplasia","volume":"75","author":"Latil","year":"2015","journal-title":"Prostate"},{"issue":"2","key":"10.1002\/14651858.CD001423.pub4-BIB0090|cit90","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1590\/S1677-5538.IBJU.2013.02.10","article-title":"Effects of Serenoa repens, selenium and lycopene (Profluss\u00ae) on chronic inflammation associated with benign prostatic hyperplasia: results of \"FLOG\" (Flogosis and Profluss in Prostatic and Genital Disease), a multicentre Italian study","volume":"39","author":"Morgia","year":"2013","journal-title":"International braz j urol: official journal of the Brazilian Society of Urology"},{"key":"10.1002\/14651858.CD001423.pub4-BIB0091|cit91","unstructured":"Sprite study https:\/\/www.isrctn.com\/ISRCTN73316039"},{"issue":"2","key":"10.1002\/14651858.CD001423.pub4-BIB0092|cit92","doi-asserted-by":"crossref","first-page":"317-325","DOI":"10.1111\/bju.14209","article-title":"Serenoa repens + selenium + lycopene vs tadalafil 5 mg for the treatment of lower urinary tract symptoms secondary to benign prostatic obstruction: a Phase IV, non-inferiority, open-label, clinical study (SPRITE study)","volume":"122","author":"Morgia","year":"2018","journal-title":"BJU International"},{"key":"10.1002\/14651858.CD001423.pub4-BIB0093|cit93","doi-asserted-by":"crossref","unstructured":"Efficacy of natural extract 2007RD01 combined with Saw Palmetto in benign prostatic hyperplasia patients compared to Saw Palmetto https:\/\/clinicaltrials.gov\/ct2\/show\/NCT00797394","DOI":"10.1016\/S0084-4071(08)70077-0"},{"issue":"4","key":"10.1002\/14651858.CD001423.pub4-BIB0094|cit94","first-page":"A226","article-title":"Serenoa repens in the treatment of human benign prostatic hyperplasia (BPH)","volume":"137","author":"Pannunzio","year":"1987","journal-title":"Journal of Urology"},{"issue":"5","key":"10.1002\/14651858.CD001423.pub4-BIB0095|cit95","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1177\/039156038605300509","article-title":"Serenoa repens vs. Gestorone caproate in the treatment of benign prostatic hypertension: a randomized study","volume":"53","author":"Pannunzio","year":"1986","journal-title":"Urologia"},{"issue":"1","key":"10.1002\/14651858.CD001423.pub4-BIB0096|cit96","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1177\/039156031007700108","article-title":"Association of Serenoa repens, Urtica dioica and Pinus pinaster. Safety and efficacy in the treatment of lower tract symptoms. Prospective study on 320 patients","volume":"77","author":"Pavone","year":"2010","journal-title":"Urologia"},{"key":"10.1002\/14651858.CD001423.pub4-BIB0097|cit97","first-page":"73","article-title":"Efficacy of pretreatment with Serenoa repens on bleeding associated with transurethral resection of prostate","volume":"56","author":"Pecoraro","year":"2004","journal-title":"Minerva Urologica e Nefrologica"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD001423.pub4-BIB0098|cit98","first-page":"103","article-title":"Symptomatic efficacy of a sabal-urtica combination preparation in the therapy of benign prostatic syndrome: results of a placebo-controlled double-blind study","volume":"147","author":"Popa","year":"2005","journal-title":"MMW Fortschritte der Medizin"},{"issue":"4","key":"10.1002\/14651858.CD001423.pub4-BIB0099|cit99","doi-asserted-by":"crossref","first-page":"e1150","DOI":"10.1016\/S1569-9056(13)62075-8","article-title":"PROSPECT study (PROStamol: perspectives of combined therapy) in patients with BPH","volume":"12","author":"Romaniuk","year":"2013","journal-title":"European urology, supplements"},{"issue":"2","key":"10.1002\/14651858.CD001423.pub4-BIB0100|cit100","first-page":"61","article-title":"Clinical controlled trial on therapeutical bioequivalence and tolerability of Serenoa repens oral capsules 160 mg or rectal capsules 640 mg","volume":"46","author":"Roveda","year":"1994","journal-title":"Archivio di Medicina Interna"},{"key":"10.1002\/14651858.CD001423.pub4-BIB0101|cit101","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1159\/000322645","article-title":"Long-term efficacy of Serenoa repens treatment in patients with mild and moderate symptomatic benign prostatic hyperplasia","volume":"86","author":"Sinescu","year":"2011","journal-title":"Urologia Internationalis"},{"issue":"4","key":"10.1002\/14651858.CD001423.pub4-BIB0102|cit102","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s001200050106","article-title":"Combined sabal and urtica extract compared with finasteride in men with benign prostatic hyperplasia: analysis of prostate volume and therapeutic outcome","volume":"36","author":"S\u00f6keland","year":"1997","journal-title":"Urologe A"},{"issue":"6","key":"10.1002\/14651858.CD001423.pub4-BIB0103|cit103","first-page":"299","article-title":"A combination preparation of sabal and urtica extract versus finasteride in benign prostatic hyperplasia (BPH)\u2014an analysis of data regarding prostatic volume and treatment success","volume":"21","author":"S\u00f6keland","year":"2000","journal-title":"Zeitschrift fur Phytotherapie"},{"key":"10.1002\/14651858.CD001423.pub4-BIB0104|cit104","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1046\/j.1464-410X.2000.00776.x","article-title":"Combined sabal and urtica extract compared with finasteride in men with benign prostatic hyperplasia: analysis of prostate volume and therapeutic outcome","volume":"86","author":"S\u00f6keland","year":"2000","journal-title":"British Journal of Urology International"},{"issue":"5","key":"10.1002\/14651858.CD001423.pub4-BIB0105|cit105","first-page":"231","article-title":"Efficacy and tolerability of the lipidosterolic extract of Serenoarepens (Permixon\u00ae) in benign prostatic hyperplasia: a double-blind comparison of two dosage regimens","volume":"16","author":"Stepanov","year":"1999","journal-title":"Advances in Therapy"},{"issue":"3","key":"10.1002\/14651858.CD001423.pub4-BIB0106|cit106","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1159\/000475388","article-title":"Comparison of finasteride (Proscar\u00ae) and Serenoa repens (Permixon\u00ae) in the inhibition of 5-alpha reductase in healthy male volunteers","volume":"26","author":"Strauch","year":"1994","journal-title":"European Urology"},{"issue":"2","key":"10.1002\/14651858.CD001423.pub4-BIB0107|cit107","first-page":"119","article-title":"Effects of Difaprost R on voiding dysfunction, histology and inflammation markers in patients with benign prostatic hyperplasia who are candidates for surgical treatment","volume":"66","author":"Suardi","year":"2014","journal-title":"Minerva urologica e nefrologica [The Italian journal of urology and nephrology]"},{"issue":"3","key":"10.1002\/14651858.CD001423.pub4-BIB0108|cit108","first-page":"S220","article-title":"BPH patients treated with phytotherapy: Results at 6 months","volume":"80","author":"Taieb","year":"2012","journal-title":"Urology"},{"issue":"7","key":"10.1002\/14651858.CD001423.pub4-BIB0109|cit109","doi-asserted-by":"crossref","first-page":"A480","DOI":"10.1016\/S1098-3015(11)73051-0","article-title":"Patients with BPH: Results at 6 months following treatment with phytotherapy versus other treatments","volume":"13","author":"Taieb","year":"2010","journal-title":"Value in Health"},{"issue":"3","key":"10.1002\/14651858.CD001423.pub4-BIB0110|cit110","first-page":"S220","article-title":"Patients with BPH: Results at 6 months with phytotherapy vs other treatments","volume":"80","author":"Taieb","year":"2012","journal-title":"Urology"},{"key":"10.1002\/14651858.CD001423.pub4-BIB0111|cit111","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1097\/01.ju.0000150533.94952.25","article-title":"Serenoa repens treatment modifies BAX\/BCL-2 index expression and CASPASE-3 activity in prostatic tissue from patients with benign prostatic hyperplasia","volume":"173","author":"Vela-Navarrete","year":"2005","journal-title":"The Journal of Urology"},{"key":"10.1002\/14651858.CD001423.pub4-BIB0112|cit112","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S0302-2838(03)00368-3","article-title":"BPH and inflammation: pharmacological effects of Permixon on histological and molecular inflammatory markers. Results of a double blind pilot clinical assay","volume":"44","author":"Vela-Navarrete","year":"2003","journal-title":"European Urology"},{"key":"10.1002\/14651858.CD001423.pub4-BIB0113|cit113","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/S0090-4295(02)01838-1","article-title":"Saw palmetto alters nuclear measurements reflecting DNA content in men with symptomatic BPH: evidence for a possible molecular mechanism","volume":"60","author":"Veltri","year":"2002","journal-title":"Urology"},{"key":"10.1002\/14651858.CD001423.pub4-BIB0114|cit114","first-page":"3","article-title":"Results of three-year clinical study of prostamol Uno efficacy and safety in patients with initial symptoms of prostatic adenoma and risk of its progression","volume":"6","author":"Vinarov","year":"2010","journal-title":"Urologiia"},{"issue":"1","key":"10.1002\/14651858.CD001423.pub4-BIB0115|cit115","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1159\/000474426","article-title":"Enzyme activities in tissue of human benign prostatic hyperplasia after three months' treatment with the Sabal serrulata extract IDS 89 (Strogen) or placebo","volume":"31","author":"Weisser","year":"1997","journal-title":"European Urology"},{"issue":"7","key":"10.1002\/14651858.CD001423.pub4-BIB0116|cit116","doi-asserted-by":"crossref","first-page":"501-509","DOI":"10.1111\/j.1442-2042.2004.00844.x","article-title":"Single-blind, randomized controlled study of the clinical and urodynamic effects of an alpha-blocker (naftopidil) and phytotherapy (eviprostat) in the treatment of benign prostatic hyperplasia","volume":"11","author":"Yamanishi","year":"2004","journal-title":"International journal of urology"},{"issue":"2","key":"10.1002\/14651858.CD001423.pub4-BIB0117|cit117","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.eururo.2005.03.029","article-title":"Evaluation of male sexual function in patients with lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia (BPH) treated with a phytotherapeutic agent (Permixon (R)), Tamsulosin or Finasteride","volume":"48","author":"Zlotta","year":"2005","journal-title":"European Urology"},{"issue":"2","key":"10.1002\/14651858.CD001423.pub4-BIB0118|cit118","first-page":"80","article-title":"Extracts Serenoa repens in the treatment of prostatic adenoma and chronic abacterial prostatitis: results of short-term (3-month courses) therapy","author":"Aliaev","year":"2007","journal-title":"Urologiia (Moscow, Russia : 1999)"},{"issue":"40","key":"10.1002\/14651858.CD001423.pub4-BIB0119|cit119","first-page":"52","article-title":"Benign prostatic syndrome. Urinary urgency and micturition frequency reduced with plant preparation","volume":"147","year":"2005","journal-title":"MMW Fortschritte der Medizin"},{"issue":"3","key":"10.1002\/14651858.CD001423.pub4-BIB0120|cit120","doi-asserted-by":"crossref","first-page":"180-186","DOI":"10.1177\/039156031007700304","article-title":"Analysis of the results obtained with a new phytotherapeutic association for LUTS versus control","volume":"77","author":"Bercovich","year":"2010","journal-title":"Urologia"},{"issue":"4","key":"10.1002\/14651858.CD001423.pub4-BIB0121|cit121","first-page":"374","article-title":"An investigation into the \"in vivo\" effect of Permixon, an extract of the American dwarf palm, Serenoa repens, on human benign prostatic hyperplasia","volume":"167","author":"Buck","year":"2002","journal-title":"Journal of Urology"},{"issue":"5","key":"10.1002\/14651858.CD001423.pub4-BIB0122|cit122","first-page":"310","article-title":"Our experience with hexanic extract of Serenoa repens in the treatment of benign prostatic hypertrophy","volume":"40","author":"Carreras","year":"1987","journal-title":"Archivos Espanoles de Urologia"},{"key":"10.1002\/14651858.CD001423.pub4-BIB0123|cit123","first-page":"15","article-title":"Permixon versus placebo; results of a multicenter study","volume":"4","author":"Cukier","year":"1985","journal-title":"Comptes Rendus de Therapeutique et de Pharmacologie Clinique"},{"issue":"5","key":"10.1002\/14651858.CD001423.pub4-BIB0124|cit124","first-page":"220","article-title":"Phytotherapy of benign prostate hyperplasia with Serenoa repens extract (permixon\u00ae)","volume":"31","author":"Dathe","year":"1991","journal-title":"Urologe - Ausgabe B"},{"issue":"2","key":"10.1002\/14651858.CD001423.pub4-BIB0125|cit125","first-page":"21","article-title":"Treatment of benign prostate hyperplasia with a combination preparation from sabal and urtica extract in urological practice","volume":"12","author":"Diehl","year":"2005","journal-title":"Journal fur Urologie und Urogynakologie"},{"key":"10.1002\/14651858.CD001423.pub4-BIB0126|cit126","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1177\/039156038305000517","article-title":"Clinical results on a new drug in the therapy of prostate hypertrophy (Permixon)","volume":"50","author":"Emili","year":"1983","journal-title":"Urologia"},{"issue":"30-31","key":"10.1002\/14651858.CD001423.pub4-BIB0127|cit127","first-page":"1616","article-title":"Sabal extract in a single daily dose in the treatment of benign prostate hyperplasia","volume":"43","author":"Fabricius","year":"1993","journal-title":"Therapiewoche"},{"key":"10.1002\/14651858.CD001423.pub4-BIB0128|cit128","first-page":"1775","article-title":"Treatment of benign prostate adenoma and chronic prostatitis","volume":"37","author":"Gabric","year":"1987","journal-title":"Therapiewoche"},{"key":"10.1002\/14651858.CD001423.pub4-BIB0129|cit129","first-page":"187","article-title":"Saw palmetto: An effective form of phytotherapy for the treatment of benign prostate hyperplasia (BPH)?","volume":"62","author":"Green","year":"2000","journal-title":"Biology of Reproduction"},{"issue":"1-2","key":"10.1002\/14651858.CD001423.pub4-BIB0130|cit130","first-page":"34","article-title":"Extractum Sabal fructus in benign prostatic hyperplasia (BPH). Stage I and II clinical trial","volume":"6","author":"L\u00f6belenz","year":"1992","journal-title":"Therapeutikon"},{"issue":"4","key":"10.1002\/14651858.CD001423.pub4-BIB0131|cit131","first-page":"247-253","article-title":"Medical treatment of the prostatism syndrome. Comparative study","volume":"40","author":"Mart\u00ednez Agull\u00f3","year":"1987","journal-title":"Archivos espanoles de urologia"},{"key":"10.1002\/14651858.CD001423.pub4-BIB0132|cit132","first-page":"346","article-title":"Drug therapy of benign prostatic hyperplasia with saw palmetto extract","volume":"2","author":"Mattei","year":"1990","journal-title":"TW Urologie Nephrologie"},{"issue":"5","key":"10.1002\/14651858.CD001423.pub4-BIB0133|cit133","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1177\/039156038805500508","article-title":"Liposterolic extract of Serenoa Repens in management of benign prostatic hypertrophy","volume":"55","author":"Mattei","year":"1988","journal-title":"Urologia"},{"issue":"1","key":"10.1002\/14651858.CD001423.pub4-BIB0134|cit134","first-page":"26","article-title":"Randomized double-blind controlled clinical trial of Serenoa repens versus placebo in the management of patients with symptomatic Grade I to Grade II benign prostatic hyperplasia (PBH)","volume":"16","author":"Mohanty","year":"1999","journal-title":"Indian Journal of Urology"},{"key":"10.1002\/14651858.CD001423.pub4-BIB0135|cit135","first-page":"137","article-title":"Serenoa repens versus placebo in management of benign prostatic hyperplasia (bph)\u2014a randomised double blind control clinical trial","author":"Mohanty","year":"1999","journal-title":"Nephrology, urology, transplantation society of SAARC, Sri Lanka"},{"issue":"6","key":"10.1002\/14651858.CD001423.pub4-BIB0136|cit136","first-page":"384","article-title":"Combination treatment of benign prostate hyperplasia with phytotherapy and selective alpha 1 blocking agents","volume":"33","author":"Neumann","year":"1993","journal-title":"Urologe - Ausgabe B"},{"issue":"2","key":"10.1002\/14651858.CD001423.pub4-BIB0137|cit137","first-page":"35","article-title":"Prostamol-uno in the treatment of benign prostatic hyperplasia","author":"Razumov","year":"2001","journal-title":"Urologiia (Moscow, Russia : 1999)"},{"key":"10.1002\/14651858.CD001423.pub4-BIB0138|cit138","unstructured":"A verification study on improvement of urination issues with ingestion of saw palmetto fruit extract: a randomized double-blind, parallel-group, placebo-controlled study https:\/\/center6.umin.ac.jp\/cgi-open-bin\/ctr_e\/ctr_view.cgi?recptno=R000039948"},{"key":"10.1002\/14651858.CD001423.pub4-BIB0139|cit139","first-page":"429","article-title":"Verification Study on the Effects of Saw Palmetto Fruit Extract on Urination Issues\u2015A Randomized Double-blind, Parallel-group, Placebo-controlled Study","volume":"48","author":"Sekikawa","year":"2020","journal-title":"Yakuritochiry\u014d [Pharmacology and Therapy]"},{"key":"10.1002\/14651858.CD001423.pub4-BIB0140|cit140","first-page":"87","article-title":"Treatment of obstructive symptomatology caused by prostatic adenoma with an extract of Serenoa repens. Double-blind clinical study vs placebo","volume":"37","author":"Tasca","year":"1985","journal-title":"Minerva Urologica e Nefrologica"},{"key":"10.1002\/14651858.CD001423.pub4-BIB0141|cit141","first-page":"87","article-title":"Treatment of obstructive symptomatology caused by prostatic adenoma with an extract of Serenoa repens. Double-blind clinical study vs. placebo","volume":"37","author":"Tasca","year":"1985","journal-title":"Minerva Urologica e Nefrologica"},{"issue":"3","key":"10.1002\/14651858.CD001423.pub4-BIB0142|cit142","first-page":"16","article-title":"Treatment of benign prostatic hypertrophy with prostaplant","author":"Tkachuk","year":"2002","journal-title":"Urologiia (Moscow, Russia : 1999)"},{"issue":"29","key":"10.1002\/14651858.CD001423.pub4-BIB0143|cit143","first-page":"1728","article-title":"Therapy of benign prostate hyperplasia with sabal fruit extract SG 291 is effective and causes few side-effects","volume":"45","author":"Fabricius","year":"1995","journal-title":"Therapiewoche"},{"issue":"6","key":"10.1002\/14651858.CD001423.pub4-BIB0144|cit144","first-page":"380","article-title":"Change of miction in patients with benign prostate hyperplasia during treatment with sabal extract","volume":"33","author":"Volp","year":"1993","journal-title":"Urologe - Ausgabe B"},{"issue":"1","key":"10.1002\/14651858.CD001423.pub4-BIB0145|cit145","first-page":"84, 86","article-title":"Safety of continuous (more than 1 year) intake of Serenoa repens extract by patients with prostatic adenoma","author":"Vinarov","year":"2009","journal-title":"Urologiia (Moscow, Russia : 1999)"},{"issue":"5","key":"10.1002\/14651858.CD001423.pub4-BIB0146|cit146","first-page":"313","article-title":"Therapy of benign prostate hyperplasia with sabal extract IDS 89: Long-term study proofs the efficiency","volume":"45","author":"Wehr","year":"1995","journal-title":"Therapiewoche"},{"key":"10.1002\/14651858.CD001423.pub4-BIB0147|cit147","unstructured":"Permixon (R) 320 mg once a day open label treatment for patients participating in the placebo controlled study https:\/\/www.isrctn.com\/ISRCTN42774128"},{"key":"10.1002\/14651858.CD001423.pub4-BIB0148|cit148","unstructured":"A double-blind, randomized, placebo-controlled clinical trial to investigate the effect of the foods containing plant extract (No.SB2805) https:\/\/center6.umin.ac.jp\/cgi-open-bin\/ctr_e\/ctr_view.cgi?recptno=R000026820"},{"key":"10.1002\/14651858.CD001423.pub4-BIB0149|cit149","unstructured":"A verification study on improvement of problems with urination due to ingestion of the food containing saw palm extracts: a randomized double-blind, parallel-group, placebo-controlled study https:\/\/center6.umin.ac.jp\/cgi-open-bin\/ctr_e\/ctr_view.cgi?recptno=R000031969"},{"key":"10.1002\/14651858.CD001423.pub4-BIB0150|cit150","unstructured":"The Effectiveness of Saw Palmetto and Sanmiaoshan on Benign Prostatic Hyperplasia in Chinese Patients https:\/\/clinicaltrials.gov\/show\/NCT00497939"},{"key":"10.1002\/14651858.CD001423.pub4-BIB0151|cit151","unstructured":"PERmixon\u00ae in LUTS Evaluation Study (PERLES) https:\/\/ClinicalTrials.gov\/show\/NCT02121613"},{"issue":"6","key":"10.1002\/14651858.CD001423.pub4-BIB0152|cit152","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/j.eururo.2014.01.019","article-title":"What is the most bothersome lower urinary tract symptom? Individual- and population-level perspectives for both men and women","volume":"65","author":"Agarwal","year":"2014","journal-title":"European Urology"},{"issue":"5","key":"10.1002\/14651858.CD001423.pub4-BIB0153|cit153","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1016\/S0022-5347(01)66780-6","article-title":"Benign prostatic hyperplasia specific health status measures in clinical research: how much change in the American Urological Association symptom index and the benign prostatic hyperplasia impact index is perceptible to patients?","volume":"154","author":"Barry","year":"1995","journal-title":"Journal of Urology"},{"issue":"1","key":"10.1002\/14651858.CD001423.pub4-BIB0154|cit154","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/S0022-5347(01)65267-4","article-title":"The natural history of patients with benign prostatic hyperplasia as diagnosed by North American urologists","volume":"157","author":"Barry","year":"1997","journal-title":"Journal of Urology"},{"issue":"3","key":"10.1002\/14651858.CD001423.pub4-BIB0155|cit155","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/j.juro.2012.08.257","article-title":"Relationships among participant international prostate symptom score, benign prostatic hyperplasia impact index changes and global ratings of change in a trial of phytotherapy in men with lower urinary tract symptoms","volume":"189","author":"Barry","year":"2013","journal-title":"Journal of Urology"},{"issue":"7","key":"10.1002\/14651858.CD001423.pub4-BIB0156|cit156","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1089\/end.2013.0805","article-title":"Morbidity and mortality after benign prostatic hyperplasia surgery: data from the American College of Surgeons national surgical quality improvement program","volume":"28","author":"Bhojani","year":"2014","journal-title":"Journal of Endourology"},{"issue":"8","key":"10.1002\/14651858.CD001423.pub4-BIB0157|cit157","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1007\/s12325-017-0577-9","article-title":"Prevalence of lower urinary tract symptoms in China, Taiwan, and South Korea: results from a cross-sectional, population-based study","volume":"34","author":"Chapple","year":"2017","journal-title":"Advances in Therapy"},{"key":"10.1002\/14651858.CD001423.pub4-BIB0158|cit158","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/S0094-0143(21)00964-2","article-title":"Clinical manifestations of benign prostatic hyperplasia and the indications for therapeutic intervention","volume":"17","author":"Christensen","year":"1990","journal-title":"Urology Clinics of North America"},{"issue":"3","key":"10.1002\/14651858.CD001423.pub4-BIB0159|cit159","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.eururo.2010.05.045","article-title":"A widespread population study of actual medical management of lower urinary tract symptoms related to benign prostatic hyperplasia across Europe and beyond official clinical guidelines","volume":"58","author":"Cornu","year":"2010","journal-title":"European Urology"},{"key":"10.1002\/14651858.CD001423.pub4-BIB0160|cit160","unstructured":"Covidence Veritas Health Innovation, Melbourne, Australia. Available at www.covidence.org"},{"issue":"4","key":"10.1002\/14651858.CD001423.pub4-BIB0161|cit161","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1016\/S0022-5347(05)00708-1","article-title":"Baseline factors as predictors of clinical progression of benign prostatic hyperplasia in men treated with placebo","volume":"175","author":"Crawford","year":"2006","journal-title":"Journal of Urology"},{"key":"10.1002\/14651858.CD001423.pub4-BIB0162|cit162","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.euros.2021.02.001","article-title":"Newer minimal-invasive treatment modalities to treat lower urinary tract symptoms attributed to benign prostatic hyperplasia","volume":"26","author":"Dahm","year":"2021","journal-title":"European Urology Open Science"},{"key":"10.1002\/14651858.CD001423.pub4-BIB0163|cit163","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1016\/j.juro.2008.01.094","article-title":"Phytotherapy for lower urinary tract symptoms secondary to benign prostatic hyperplasia","volume":"179","author":"Dedhia","year":"2008","journal-title":"The Journal of Urology"},{"key":"10.1002\/14651858.CD001423.pub4-BIB0164|cit164","unstructured":"Deeks JJ Higgins JP Chapter 10: Analysing data and undertaking meta-analyses. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editor(s). Cochrane Handbook for Systematic Reviews of Interventions version 6.3 (updated February 2022). Cochrane, 2022 Available from www.training.cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD001423.pub4-BIB0165|cit165","first-page":"143","article-title":"Plant extracts in benign prostatic hyperplasia","volume":"45","author":"Di Silverio","year":"1993","journal-title":"Minerva Urologica e Nefrologica"},{"key":"10.1002\/14651858.CD001423.pub4-BIB0166|cit166","first-page":"944","article-title":"Indentifying relevant studies for systematic reviews","volume":"312","author":"Dickersin","year":"1994","journal-title":"BMJ"},{"issue":"1","key":"10.1002\/14651858.CD001423.pub4-BIB0167|cit167","first-page":"8","article-title":"Conservative nonhormonal treatment of patients with benign prostatic hyperplasia","volume":"29","author":"Dreikorn","year":"1990","journal-title":"Urologe A"},{"issue":"2","key":"10.1002\/14651858.CD001423.pub4-BIB0168|cit168","first-page":"51","article-title":"Relationship between depression and lower urinary tract symptoms secondary to benign prostatic hyperplasia","volume":"17","author":"Dunphy","year":"2015","journal-title":"Reviews in Urology"},{"key":"10.1002\/14651858.CD001423.pub4-BIB0169|cit169","volume-title":"Management of Non-Neurogenic Male Lower Urinary Tract Symptoms (LUTS), incl. Benign Prostatic Obstruction (BPO)","author":"European Association of Urology","year":"2022"},{"issue":"3","key":"10.1002\/14651858.CD001423.pub4-BIB0170|cit170","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.ucl.2016.04.001","article-title":"The epidemiology of benign prostatic hyperplasia associated with lower urinary tract symptoms: prevalence and incident rates","volume":"43","author":"Egan","year":"2016","journal-title":"Urologic Clinics of North America"},{"key":"10.1002\/14651858.CD001423.pub4-BIB0171|cit171","unstructured":"Flemyng E Moore TH Boutron I Higgins JPT Hr\u00f3bjartsson A Nejstgaard CH Dwan K Using Risk of Bias 2 to assess results from randomised controlled trials: guidance from Cochrane BMJ Evidence Based Medicine 10.1136\/bmjebm-2022-112102"},{"issue":"6","key":"10.1002\/14651858.CD001423.pub4-BIB0172|cit172","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004135.pub4","article-title":"Transurethral microwave thermotherapy for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia","author":"Franco","year":"2021","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD001423.pub4-BIB0173|cit173","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.prnil.2023.01.002","article-title":"Update on the management of benign prostatic hyperplasia and the role of minimally invasive procedures","volume":"11","author":"Franco","year":"2023","journal-title":"Prostate International"},{"key":"10.1002\/14651858.CD001423.pub4-BIB0174|cit174","unstructured":"GRADEpro GDT McMaster University and Evidence Prime"},{"key":"10.1002\/14651858.CD001423.pub4-BIB0175|cit175","unstructured":"Gravas S Cornu JN Gacci M Gratzke C Herrmann TRW Mamoulakis C EAU Guidelines on Management of Non-Neurogenic Male Lower Urinary Tract Symptoms (LUTS), incl. Benign Prostatic Obstruction (BPO) European Association of Urology. Available at: https:\/\/uroweb.org\/guidelines\/management-of-non-neurogenic-male-luts (Accessed 7 June 2023) 2022"},{"issue":"7651","key":"10.1002\/14651858.CD001423.pub4-BIB0176|cit176","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1136\/bmj.39490.551019.BE","article-title":"What is \"quality of evidence\" and why is it important to clinicians?","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ (Clinical Research Ed.)"},{"issue":"4","key":"10.1002\/14651858.CD001423.pub4-BIB0177|cit177","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.jclinepi.2010.04.026","article-title":"GRADE guidelines: 1. Introduction\u2014GRADE evidence profiles and summary of findings tables","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"3","key":"10.1002\/14651858.CD001423.pub4-BIB0178|cit178","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1038\/sj.pcan.4500746","article-title":"Not all brands are created equal: a comparison of selected components of different brands of Serenoa repens extract","volume":"7","author":"Habib","year":"2004","journal-title":"Prostate Cancer and Prostatic Diseases"},{"key":"10.1002\/14651858.CD001423.pub4-BIB0179|cit179","unstructured":"Higgins JPT Thomas J Chandler J Cumpston M Li T Page MJ Cochrane Handbook for Systematic Reviews of Interventions version 6.3 (updated February 2022). Cochrane, 2022 Available from www.training.cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD001423.pub4-BIB0180|cit180","unstructured":"Higgins JPT Savovi\u0107 J Page MJ Elbers RG Sterne JAC Chapter 8: Assessing risk of bias in a randomized trial. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editor(s). Cochrane Handbook for Systematic Reviews of Interventions version 6.3 (updated February 2022). Cochrane, 2022 Available from www.training.cochrane.org\/handbook"},{"issue":"1","key":"10.1002\/14651858.CD001423.pub4-BIB0181|cit181","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/j.1442-2042.1997.tb00138.x","article-title":"Epidemiologic survey of lower urinary tract symptoms in Asia and Australia using the international prostate symptom score","volume":"4","author":"Homma","year":"1997","journal-title":"International Journal of Urology : Official Journal of the Japanese Urological Association"},{"issue":"4","key":"10.1002\/14651858.CD001423.pub4-BIB0182|cit182","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/0197-2456(89)90005-6","article-title":"Measurement of health status. Ascertaining the minimal clinically important difference","volume":"10","author":"Jaeschke","year":"1989","journal-title":"Controlled Clinical Trials"},{"key":"10.1002\/14651858.CD001423.pub4-BIB0183|cit183","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/1477-7525-11-109","article-title":"Patient-reported outcomes in meta-analyses\u2014Part 1: assessing risk of bias and combining outcomes","volume":"11","author":"Johnston","year":"2013","journal-title":"Health and Quality of Life Outcomes"},{"key":"10.1002\/14651858.CD001423.pub4-BIB0184|cit184","doi-asserted-by":"publisher","first-page":"e073725","DOI":"10.1136\/bmj-2022-073725","article-title":"CONSORT Harms 2022 statement, explanation, and elaboration: updated guideline for the reporting of harms in randomised trials","volume":"381","author":"Junqueira","year":"2023","journal-title":"BMJ"},{"issue":"2","key":"10.1002\/14651858.CD001423.pub4-BIB0185|cit185","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1111\/bju.12802","article-title":"Baseline characteristics predict risk of progression and response to combined medical therapy for benign prostatic hyperplasia (BPH)","volume":"115","author":"Kozminski","year":"2015","journal-title":"BJU International"},{"key":"10.1002\/14651858.CD001423.pub4-BIB0186|cit186","first-page":"39","article-title":"Clinical trials in psychiatry: should protocol deviation censor patient data?","volume":"6","author":"Lavori","year":"1992","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"10.1002\/14651858.CD001423.pub4-BIB0187|cit187","doi-asserted-by":"crossref","first-page":"7984","DOI":"10.1038\/s41598-017-06628-8","article-title":"The global burden of lower urinary tract symptoms suggestive of benign prostatic hyperplasia: a systematic review and meta-analysis","volume":"7","author":"Lee","year":"2017","journal-title":"Scientific Reports"},{"issue":"2","key":"10.1002\/14651858.CD001423.pub4-BIB0188|cit188","doi-asserted-by":"crossref","first-page":"137","DOI":"10.3109\/00365597909181168","article-title":"The weight of the human prostate","volume":"13","author":"Leissner","year":"1979","journal-title":"Scandinavian Journal of Urology and Nephrology"},{"issue":"4","key":"10.1002\/14651858.CD001423.pub4-BIB0189|cit189","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1097\/JU.0000000000002183","article-title":"Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: AUA GUIDELINE PART I-Initial Work-up and Medical Management","volume":"206","author":"Lerner","year":"2021","journal-title":"Journal of Urology"},{"issue":"1","key":"10.1002\/14651858.CD001423.pub4-BIB0190|cit190","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1186\/s12877-022-03415-7","article-title":"Efficacy and safety of adrenergic alpha-1 receptor antagonists in older adults: a systematic review and meta-analysis supporting the development of recommendations to reduce potentially inappropriate prescribing","volume":"22","author":"Mansbart","year":"2022","journal-title":"BMC Geriatrics"},{"issue":"1","key":"10.1002\/14651858.CD001423.pub4-BIB0191|cit191","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.juro.2013.06.018","article-title":"Risk factors for progression or improvement of lower urinary tract symptoms in a prospective cohort of men","volume":"191","author":"Martin","year":"2014","journal-title":"Journal of Urology"},{"key":"10.1002\/14651858.CD001423.pub4-BIB0192|cit192","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1001\/jama.1995.03520320015008","article-title":"Growing use of medicinal botanicals forces assessment by drug regulators","volume":"273","author":"Marwick","year":"1995","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD001423.pub4-BIB0193|cit193","doi-asserted-by":"crossref","first-page":"115","DOI":"10.2147\/MDER.S60780","article-title":"Benign prostatic hyperplasia and new treatment options\u2014a critical appraisal of the UroLift system","volume":"9","author":"McNicholas","year":"2016","journal-title":"Medical Devices"},{"issue":"5","key":"10.1002\/14651858.CD001423.pub4-BIB0194|cit194","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1016\/j.juro.2011.01.074","article-title":"Update on AUA guideline on the management of benign prostatic hyperplasia","volume":"185","author":"McVary","year":"2011","journal-title":"Journal of Urology"},{"key":"10.1002\/14651858.CD001423.pub4-BIB0195|cit195","unstructured":"Microsoft Excel Microsoft Corporation 2023"},{"issue":"5","key":"10.1002\/14651858.CD001423.pub4-BIB0196|cit196","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.euf.2016.04.002","article-title":"Efficacy and Safety of Hexanic Lipidosterolic Extract of Serenoa repens (Permixon) in the Treatment of Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia: Systematic Review and Meta-analysis of Randomized Controlled Trials","volume":"2","author":"Novara","year":"2016","journal-title":"Eur Urol Focus"},{"key":"10.1002\/14651858.CD001423.pub4-BIB0197|cit197","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD001423.pub4-BIB0198|cit198","unstructured":"Page MJ Higgins JPT Sterne JAC Chapter 13: Assessing risk of bias due to missing results in a synthesis. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.3 (updated February 2022). Cochrane, 2022 Available from www.training.cochrane.org\/handbook"},{"issue":"4","key":"10.1002\/14651858.CD001423.pub4-BIB0199|cit199","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.urology.2015.06.048","article-title":"National trends of simple prostatectomy for benign prostatic hyperplasia with an analysis of risk factors for adverse perioperative outcomes","volume":"86","author":"Pariser","year":"2015","journal-title":"Urology"},{"issue":"2","key":"10.1002\/14651858.CD001423.pub4-BIB0200|cit200","doi-asserted-by":"publisher","first-page":"e024537","DOI":"10.1136\/bmjopen-2018-024537.","article-title":"Analysis and reporting of adverse events in randomised controlled trials: a review","volume":"9","author":"Phillips","year":"2019","journal-title":"BMJ Open"},{"issue":"5","key":"10.1002\/14651858.CD001423.pub4-BIB0201|cit201","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1111\/bju.12994","article-title":"Patients not P values","volume":"115","author":"Rees","year":"2015","journal-title":"BJU International"},{"key":"10.1002\/14651858.CD001423.pub4-BIB0202|cit202","unstructured":"Review Manager Web (RevMan Web) The Cochrane Collaboration 2022"},{"issue":"1","key":"10.1002\/14651858.CD001423.pub4-BIB0203|cit203","first-page":"14","article-title":"Current medical therapies for men with lower urinary tract symptoms and benign prostatic hyperplasia: achievements and limitations","volume":"10","author":"Roehrborn","year":"2008","journal-title":"Reviews in Urology"},{"key":"10.1002\/14651858.CD001423.pub4-BIB0204|cit204","volume-title":"Campbell Walsh Wein Urology","author":"Roehrborn","year":"2020"},{"issue":"2","key":"10.1002\/14651858.CD001423.pub4-BIB0205|cit205","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.euf.2020.01.002","article-title":"Clinical Efficacy of Serenoa repens Versus Placebo Versus Alpha-blockers for the Treatment of Lower Urinary Tract Symptoms\/Benign Prostatic Enlargement: A Systematic Review and Network Meta-analysis of Randomized Placebo-controlled Clinical Trials","volume":"7","author":"Russo","year":"2021","journal-title":"Eur Urol Focus"},{"key":"10.1002\/14651858.CD001423.pub4-BIB0206|cit206","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.jclinepi.2015.12.006","article-title":"Improving GRADE evidence tables part 3: detailed guidance for explanatory footnotes supports creating and understanding GRADE certainty in the evidence judgments","volume":"74","author":"Santesso","year":"2016","journal-title":"J Clin Epidemiol"},{"key":"10.1002\/14651858.CD001423.pub4-BIB0207|cit207","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.jclinepi.2019.10.014","article-title":"GRADE guidelines 26: informative statements to communicate the findings of systematic reviews of interventions","volume":"119","author":"Santesso","year":"2020","journal-title":"J Clin Epidemiol"},{"issue":"4","key":"10.1002\/14651858.CD001423.pub4-BIB0208|cit208","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1159\/000161128","article-title":"Comparison of the potency of different brands of Serenoa repens extract on 5alpha-reductase types I and II in prostatic co-cultured epithelial and fibroblast cells","volume":"82","author":"Scaglione","year":"2008","journal-title":"Pharmacology"},{"key":"10.1002\/14651858.CD001423.pub4-BIB0209|cit209","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1001\/jama.1995.03520290060030","article-title":"Empirical evidence of bias: dimensions of methodological quality associated with estimates of treatment effects in controlled trials","volume":"273","author":"Schulz","year":"1995","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD001423.pub4-BIB0210|cit210","unstructured":"Sch\u00fcnemann HJ Higgins JPT Vist GE Glasziou P Akl EA Skoetz N Chapter 14: Completing \u2018Summary of findings\u2019 tables and grading the certainty of the evidence. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editor(s), Cochrane Handbook for Systematic Reviews of Interventions version 6.3 (updated February 2022). Cochrane, 2022 Available from www.training.cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD001423.pub4-BIB0211|cit211","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1002\/1097-0045(20001101)45:3<259::AID-PROS9>3.0.CO;2-G","article-title":"Induction of apoptosis and inhibition of cell proliferation by the lipido-sterolic extract of Serenoa repens (LSESr, Permixon\u00ae) in benign prostatic hyperplasia","volume":"45","author":"Vacherot","year":"2000","journal-title":"The Prostate"},{"issue":"6","key":"10.1002\/14651858.CD001423.pub4-BIB0212|cit212","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1111\/bju.14362","article-title":"Efficacy and safety of a hexanic extract of Serenoa repens (Permixon(\u00ae) ) for the treatment of lower urinary tract symptoms associated with benign prostatic hyperplasia (LUTS\/BPH): systematic review and meta-analysis of randomised controlled trials and observational studies","volume":"122","author":"Vela-Navarrete","year":"2018","journal-title":"BJU Int"},{"key":"10.1002\/14651858.CD001423.pub4-BIB0213|cit213","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1002\/(SICI)1097-0045(199605)28:5<300::AID-PROS5>3.0.CO;2-F","article-title":"Effects of the sabal serrulata extract IDS 89 and its subfractions on 5 alpha-reductase activity in human benign prostatic hyperplasia","volume":"28","author":"Weisser","year":"1996","journal-title":"The Prostate"},{"key":"10.1002\/14651858.CD001423.pub4-BIB0214|cit214","unstructured":"World Health Organization Proposed working definition of an older person in Africa for the MDS project \u00a0www.who.int\/healthinfo\/survey\/ageingdefnolder\/en (accessed 17 August 2017)"},{"issue":"1","key":"10.1002\/14651858.CD001423.pub4-BIB0215|cit215","doi-asserted-by":"publisher","first-page":"30","DOI":"10.4111\/icu.2016.57.1.30","article-title":"Korean clinical practice guideline for benign prostatic hyperplasia","volume":"57","author":"Yeo","year":"2016","journal-title":"Investigative and clinical urology"},{"issue":"2","key":"10.1002\/14651858.CD001423.pub4-BIB0216|cit216","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001423.pub2","article-title":"Serenoa repens for benign prostatic hyperplasia","author":"Tacklind","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"12","key":"10.1002\/14651858.CD001423.pub4-BIB0217|cit217","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001423.pub3","article-title":"Serenoa repens for benign prostatic hyperplasia","author":"Tacklind","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"5","key":"10.1002\/14651858.CD001423.pub4-BIB0218|cit218","doi-asserted-by":"publisher","first-page":"520","DOI":"10.4111\/icu.20210254","article-title":"Serenoa repens for the treatment of lower urinary tract symptoms due to benign prostatic enlargement: A systematic review and meta-analysis","volume":"62","author":"Trivisonno","year":"2021","journal-title":"Investigative Clinical Urology"},{"issue":"2","key":"10.1002\/14651858.CD001423.pub4-BIB0219|cit219","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001423","article-title":"Serenoa repens for benign prostatic hyperplasia","author":"Wilt","year":"2000","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD001423.pub4-BIB0220|cit220","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001423","article-title":"Serenoa repens for benign prostatic hyperplasia","author":"Wilt","year":"2002","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","deposited":{"date-parts":[[2025,5,12]],"date-time":"2025-05-12T23:03:34Z","timestamp":1747091014000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD001423.pub4"}},"subtitle":[],"editor":[{"name":"Cochrane Urology Group","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2023,6,22]]},"references-count":220,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2023,6]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd001423.pub4","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,22]]}}}